Philippine FDA to Ban Flavored E-Cigarette Products in 2022

May.26.2022
Effective May 25, 2022, Philippines FDA will prohibit flavored e-cigarettes and additives besides regular tobacco or menthol.

The Philippine Food and Drug Administration (FDA) has announced to all stakeholders, government agencies, and the public that effective May 25, 2022, the manufacturing, trading, distribution, importation, wholesale, retail, and online retail/wholesale of flavored electronic cigarette liquids will no longer be permitted.

 

According to Republic Act No. 11467 and its implementing rules and regulations, the manufacture, trade, distribution, importation, wholesale, retail, and online sale or wholesale of flavored electronic cigarette products (ECPs) other than ordinary tobacco or ordinary menthol are prohibited.

 

Furthermore, as stated in Executive Order 106, it should be prohibited to add electronic cigarette liquids that have been proven or suspected to be attractive or enticing to individuals under the age of twenty-one (21), toxic, harmful, addictive, or allergenic.

 

If you have any questions or inquiries, please contact CCHUHSRR at (02) 857-1900 local 8107 or 8113, or through email at ntru@fda.gov.ph.

 

Click to download: FDA Announcement Number 2022-1069.

 

Source: Philippine Food and Drug Administration

 

Please refer to official sources for accurate information.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock
2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock
2Firsts observed on FOGER’s online retail site “FOGER VAPES” that the platform indicates restocking delays due to customs and tariff factors. Several items show limited availability or “sold out” status, with a restock alert feature offered. A previous article on the site also referenced potential tariff changes that may affect pricing.
Nov.05
Argentine province of Santa Fe passes bill expanding smoking regulations to include e-cigarettes and heated tobacco products
Argentine province of Santa Fe passes bill expanding smoking regulations to include e-cigarettes and heated tobacco products
The Santa Fe Provincial Chamber of Deputies has passed a bill amending the 2005 Provincial Anti-Smoking Law (No. 12,432) to include e-cigarettes, vaping devices, and heated tobacco products. Lawmaker Sonia Martorano, who authored the initiative, said the reform aims to strengthen prevention policies amid growing youth use, stressing that “even without nicotine, these devices are toxic.”
Nov.05 by 2FIRSTS.ai
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac concluded successfully under the theme “From Change to Opportunity,” focusing on the global harm-reduction landscape, shifts in the U.S. market, dynamics in China’s supply chain, vaping product trends, and capital-market opportunities. 2Firsts International Editor-in-Chief Taco Tuinstra, compliance expert Kurt Yang, co-founder Echo Guo, and CEO Alan Zhao shared frontline insights, drawing on UK MHRA registration data and China customs export data to present a compreh
Sep.20
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
84% of Britons Back Regulation of Nicotine Pouches, Survey Finds
84% of Britons Back Regulation of Nicotine Pouches, Survey Finds
A Northerner survey finds 84% of Britons support regulating nicotine pouches and 82% back a licensing scheme for vape sales, aligning with the Tobacco and Vapes Bill to improve consumer safety and youth protection.
Nov.06 by 2FIRSTS.ai
Interview with Vabeen CEO Shuai: Full-Portfolio Push, Compliance-First Strategy to Build Global Competitiveness
Interview with Vabeen CEO Shuai: Full-Portfolio Push, Compliance-First Strategy to Build Global Competitiveness
At InterTabac 2025, Vabeen CEO Shuai told 2Firsts that Vabeen has launched two flagship products—the multi-flavor pod-mod iPlex and the open-system Billow Pro—while showcasing a complete lineup spanning disposables, pod systems, and open systems. In his view, Vabeen treats “compliance-first” as a long-term strategy and sees strict regulation as an opportunity for industry upgrading. Over the next two to three years, Vabeen will continue to focus on three pillars—compliance, user experience, and
Sep.19